Comerica Bank
FULC icon

Comerica Bank’s Fulcrum Therapeutics FULC Stock Holding History

Comerica Bank’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.25K Buy
+287
New +$2.92K ﹤0.01% 3476

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Comerica Bank's FULC Position: Q4 2025 in Review

Comerica Bank opened a new position in Fulcrum Therapeutics (FULC) in Q4 2025: 287 shares worth $3.25K. The stake represents ﹤0.01% of the portfolio and ranks #3476 among its holdings.

172 funds tracked by Wall St. Rank hold FULC as of Q4 2025.

  • Comerica Bank held 287 shares of Fulcrum Therapeutics worth $3.25K as of Q4 2025.
  • Fulcrum Therapeutics was a new Comerica Bank position in Q4 2025.
  • Fulcrum Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3476 holding.
  • 172 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.